Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico.

Gonz?lez-Mel?ndez A, B?ez-Negr?n L, R?os-Rivera R, Franco-O'Connell AS, Nieves-Plaza M, Vil? LM. Short- and mid-term outcomes in systemic lupus erythematosus patients presenting with disease exacerbation after SARS-CoV-2 mRNA vaccination: A cohort study from Puerto Rico. Lupus. 2023 Apr; 32(4):571-579.

View in: PubMed

subject areas

Cohort Studies
Disease Progression
Humans
Lupus Erythematosus, Systemic
Puerto Rico
RNA, Messenger
Severity of Illness Index
Vaccination

authors with profiles

Luis M. Vilá

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support